Faster breast biopsy analysis with mass spectrometry and AI
Part of Cancer, Skin clinical trials.
This trial uses a small mass spectrometer and artificial intelligence to quickly analyze breast tissue during a stereotactic biopsy. It aims to speed up detection and improve early diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a vacuum-assisted stereotactic breast biopsy.
- You are able to sign a consent form agreeing to participate.
- You are willing to have an extra tissue sample taken for rapid analysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an artificial intelligence (AI) system can help a second reader interpret routine breast screening mammograms. It may improve how consistently images are assessed, especially when the first reader calls them normal or benign.
This trial uses ultrasound to see if an AI tool can better find small markers placed in the breast during a biopsy. It might help improve follow-up care and make future procedures more precise.
This study tests a new artificial intelligence software called Kenko Breast AI+ that analyzes breast MRI scans to help doctors better detect and monitor breast cancer. If you've had or are planning to have a breast MRI for cancer concerns, this trial might be right for you.
This study looks at mammogram images of women who are scheduled to have one or both breasts removed (mastectomy). Researchers want to learn about patterns in breast tissue to improve future breast cancer screening.
This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.
This study tests a new, non-contact thermal camera (thermography) combined with artificial intelligence to find breast cancer. It is designed for women coming for routine screening, high-risk screening, or diagnostic exams, and aims to see if this painless, radiation-free method can help detect cancer earlier.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.